Presurgical immune-oncology/tyrosine kinase inhibitor combination therapy for renal cell carcinoma with a vena cava tumor thrombus: a single-institution case series

BACKGROUND: Although current guidelines recommend administering adjuvant immunotherapy following resection of advanced primary renal cell carcinoma (RCC), the clinical benefit of presurgical immunotherapy for patients with RCC remains uncertain. CASE DESCRIPTION: We conducted a retrospective analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Urabe, Fumihiko, Iwatani, Kosuke, Hashimoto, Masaki, Suzuki, Hirotaka, Miyajima, Keiichiro, Murakami, Masaya, Tashiro, Kojiro, Tsuzuki, Shunsuke, Furuta, Akira, Sato, Shun, Takahashi, Hiroyuki, Kimura, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481191/
https://www.ncbi.nlm.nih.gov/pubmed/37680224
http://dx.doi.org/10.21037/tau-23-203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481191/
https://www.ncbi.nlm.nih.gov/pubmed/37680224
http://dx.doi.org/10.21037/tau-23-203

Ejemplares similares